INTRODUCTION
Since bilirubin levels are universally elevated in neonates, there has been much speculation as to whether this is a clinically beneficial physiologic phenomenon. Alternatively, it could be merely the cost nature charges for allowing free placental flow of a nonwatersoluble molecule that cannot be excreted by the kidneys. Years ago, the discovery was made that bilirubin has scavenger antioxidant activity in vitro. 1 This finding has prompted numerous attempts to demonstrate its in vivo significance. There have been reports in this effect in adults 2 and in animal models. 3 However, the effects of neonatal bilirubin levels on the incidence of diseases thought to be caused by oxygen free-radical damage, such as retinopathy of prematurity (ROP), have yielded conflicting results. Whereas some [4] [5] [6] [7] have found a marginally beneficial role for elevated bilirubin levels, others [8] [9] [10] [11] have shown there is little significance to the levels and in some cases, 12, 13 elevated bilirubin levels may have been a risk factor. None of the previous reports controlled for birthweight differences before correlating the risk for ROP with bilirubin. Sample size was also a limiting factor in many of these studies. Therefore, we decided to examine whether there was a relation between peak bilirubin levels and ROP in very low birthweight (VLBW) infants (<1500 g). We studied the entire population, and those who had prolonged oxygen dependence, and, presumably, greater free-radical exposure. Furthermore, we controlled for weight and for the presence or absence of intraventricular hemorrhage (IVH), by far the most common type of hemorrhage in the VLBW infant. Both are the most common independent causes of elevated bilirubin levels. 14, 15 By controlling for the two with our large sample size, we hoped to gain a more definitive answer.
METHODS

Patients
Data of all infants weighing <1500 g and admitted to the neonatal ICU (NICU) between 1992 and 1999 were reviewed. Infants were excluded if they had exchange transfusion, were transferred out of the NICU or died. IVH was diagnosed by cranial ultrasounds read by radiologists. Evaluations for ROP were carried out by a pediatric ophthalmologist at 4 to 6 weeks of age and then as frequently as needed. Stages III and IV were used for the analysis because of their clinical significance.
A subgroup of patients with prolonged (Z28 days) oxygen requirement was also analyzed.
Bilirubin Management
Serum bilirubin level is measured in all VLBW infants in the first 24 hours of age. Levels are then followed at least daily in the first week of life. Infants with visible jaundice or bruises or who are receiving phototherapy have their bilirubin checked earlier and more frequently according to the decision of the managing physician. Phototherapy is not given prophylactically in our NICU.
Statistical Analysis
Statistical analyses were carried out using the SAS s software (Cary, NC). Odds ratios were tested for peak bilirubin levels and the risk for incidence of ROP stages III and IV. Odds ratios were created using a multiple logistic regression model controlling for birth-weight and IVH, testing weight and IVH as interactive variables.
Analysis was repeated on a subgroup of infants who had prolonged O 2 dependence (Z28 days). Odds ratios were tested for peak bilirubin levels and the risk of incidence of ROP, stages III and IV.
RESULTS
A total of 240 VLBW infants were included in this study. Of them, 90 infants had O 2 requirement Z28 days. The characteristics of the study population are shown in Table 1 .
Consistent with previous studies, 14, 15 patients with elevated bilirubin levels had a higher incidence of IVH (OR 1.264; 95%; CI 1.083 to 1.475; p ¼ 0.003) ( Table 2 ). Birthweight and peak bilirubin levels were correlated as well ( p<0.05). Higher birthweight was, as expected, protective from ROP III/IV and from prolonged oxygen use ( p<0.05). The presence of IVH appeared to have no effect on the incidence of ROP or length of oxygen use in all patients and in the subgroup of patients with prolonged oxygen use ( p>0.05).
Relation between Peak Bilirubin Levels and ROP Controlling for birthweight and for the presence of IVH, elevated peak bilirubin levels were associated with an increased risk for ROP III/IV (Table 2) (OR 1.187; 95% CI 1.013 to 1.390; p ¼ 0.034). The odds ratio is the increased risk for ROP per unit increase in peak bilirubin level. On further analysis, infants who did not have any IVH, the risk for ROP III/IV was increased when the peak bilirubin level was increased (OR 1.227; 95% CI 1.021 to 1.476; p ¼ 0.030). In infants with IVH, there was no association between bilirubin levels and ROP ( p ¼ 0.653). Finally, in the subgroup of infants with oxygen use Z28 days, there was no association between ROP III/IV and elevated peak bilirubin. ( p ¼ 0.295) ( Table 2) .
Relation between Peak Bilirubin Levels and Duration of Oxygen Requirement
In order to assess the relation between bilirubin and duration of oxygen use, bilirubin levels were divided evenly into three terciles. Controlling for birthweight and the presence of IVH, elevated peak bilirubin levels from one tercile to the next were not associated with a statistically significant difference in days of oxygen use in all patients (using the Wilcoxon nonparametric procedure ( p>0.05)). However, in the subgroup of patients with longer oxygen use (Z28 days), there was a significant increase in days of oxygen requirement as peak bilirubin levels increased ( p ¼ 0.0344) ( Table 3) .
DISCUSSION
Our results indicate that elevated peak bilirubin levels are not protective against ROP III/IV. In fact, when studying the entire population, while controlling for weight and IVH, peak bilirubin is indeed a risk factor for ROP III/IV. In the subgroup of infants with prolonged oxygen use Z28 days, increasing peak bilirubin levels were associated with even more prolonged oxygen requirement, but were not associated with either risk or protection from ROP III/IV. Across the entire population, days of oxygen use were not correlated with peak bilirubin levels. Therefore, the contribution of increased oxygen F and resulting free-radical damage F is less likely to explain our findings. A number of studies have looked at this issue, usually focusing on ROP. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In most of these studies, neither increasing birthweight was controlled for nor was the presence of IVH. Both of these variables contribute to elevated peak bilirubin levels. 14, 15 Increasing birthweight is itself associated with protection from ROP. We, too, found that before controlling for birthweight, elevated peak bilirubin levels were associated with protection from ROP III/IV ( p<0.05). Controlling for IVH, however, did not significantly alter the risk for ROP III/IV (data not shown, p>0.1). Another major difference in our study was that we used the peak bilirubin level as a continuous and independent variable. This method would more accurately predict any causal relation with ROP disease.
Peak bilirubin levels may not correlate with the amount of antioxidant activity that bilirubin is exerting on a particular infant. Mean bilirubin levels over time or area under the curve may better correlate with such antioxidant activity. We chose the peak level, however, because it is the level that clinicians will act upon it and decide for a particular management strategy. Another reason for us to use peak bilirubin levels for analysis is to eliminate the subjectivity involved with managing bilirubin levels over time, and to ensure accuracy in recording given the large sample size involved.
Bilirubin could be consumed by oxidative stresses that occur early in life. In a large study of term infants, neonates who encountered adverse peripartum events had their initial bilirubin levels significantly lower than those who did not. 6 This study further demonstrates the difficulty of using serum bilirubin levels as measures of its in vivo activity. Bilirubin production may also be upregulated in response to free radicals. 16 As a result, the balance between consumption and upregulation may yield conflicting data. This may explain why we found peak bilirubin is associated with increased ROP III/IV without changing the duration of oxygen use on the one hand, while the duration of oxygen use was increased in the subpopulation with prolonged oxygen use on the other. Further, our finding cannot indicate whether elevated peak bilirubin level is a marker for or is an influential member in the battle against oxidative stress.
There are several possibilities as to why peak bilirubin levels were not associated with increased risk for ROP in the subgroup of infants with prolonged oxygen requirement. One explanation may be that sicker infants are less capable of mounting an effective response to free-radical insult by upregulating bilirubin production. Another could be increased consumption of bilirubin in this population. Finally, the causal relation between oxygen requirement and ROP may obviate variations in bilirubin levels.
The clinically relevant significance as to whether bilirubin has a role in protecting against ROP in premature infants lies for the most part in deciding whether to reduce phototherapy in order to maintain higher bilirubin levels. Our results suggest that an elevated peak bilirubin level is a risk factor for ROP, and therefore levels need to be maintained lower. However, previous studies suggested that generalized light reduction has been associated with decreased risk for ROP, 17, 18 while reduction of light specifically to eyes appears not to be as effective. 19, 20 Clearly, prospective studies tracking serum bilirubin and other antioxidant activity in response to varying levels of phototherapy and then correlating them with protection or risk from free-radical-induced disease will be required before establishing bilirubin as a clinically significant antioxidant. Before that, elevated peak bilirubin levels should be handled with caution.
